Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Mitotic and Proliferative Indices in WHO Grade III Meningioma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genome-Wide Circular RNA Expression Patterns Reflect Resistance to Immunomodulatory Drugs in Multiple Myeloma Cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Optimal Systemic Treatment of Advanced Bladder Cancer-A Moving Target

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. TERT promoter mutations in primary and secondary WHO grade III meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Safe handling of veins in the pineal region-a mixed method study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Preoperative antibiotic prophylaxis regimen in brain tumour surgery in Sweden: a quasi-experimental study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Meningiomas with inherently high mitotic indices and poor prognosis, such as WHO grade III meningiomas, have not been investigated separately to establish interchangeability between conventional mitotic index counted on H&E stained slides (MI) and mitotic index counted on phosphohistone-H3 stained slides (PHH3 MI). This study investigates the agreement of MI and PHH3 MI and to analyze the association of progression-free survival (PFS) and MI, PHH3 MI, and the proliferative index (PI, Ki-67) in WHO grade III meningioma. Tumor specimens from 24 consecutive patients were analyzed for expression of Ki-67, PHH3 MI, and MI. Quantification was performed independently by two observers who made replicate counts in hot spots and overall tumor staining. Repeatability in replicate counts from MI and PHH3 MI was low in both observers. Consequently, we could not report the agreement. MI, PHH3 MI and hot spot counts of Ki-67 were associated with PFS (MI hot spot HR = 1.61, 95% CI 1.12-2.31, p = 0.010; PHH3 MI hot spot HR = 1.59, 95% CI 1.15-2.21, p = 0.006; Ki-67 hot spot HR = 1.06, 95% CI 1.02-1.11. p = 0.004). We found markedly low repeatability of manually counted MI and PHH3 MI in WHO grade III meningioma, and we could not conclude that the two methods agreed. Subsequently, quantification with better repeatability should be sought. All three biomarkers were associated with PFS.

OriginalsprogEngelsk
TidsskriftCancers
Vol/bind12
Udgave nummer11
ISSN2072-6694
DOI
StatusUdgivet - 2020

ID: 61630295